Sign in
Taking peopleNo phase

Ceylon cinnamon supplement for people with painful diabetic nerve damage

Tests Ceylon cinnamon capsules against placebo in adults with painful diabetic peripheral neuropathy.

Key facts

Who runs it
JAWAD AHMAD ABU-SHENNAR
Where
Jordan1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
The Effects of Ceylon Cinnamon (Cinnamomum Verum) Supplementation on Blood Glucose, Lipid Profile Levels, Body Mass Index, and Pain Intensity Among Adult Individuals With Painful Diabetic Peripheral Neuropathy
Status
Recruiting
People taking part
164 people, planned
Started
1 Feb 2026
Planned end
30 Jul 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Ceylon Cinnamon Supplement
Record updated
3 August 2026

Who can take part

The trial is looking for adults with type 2 diabetes who have painful nerve damage in the feet or hands caused by diabetes (painful diabetic peripheral neuropathy).

Age
18 years or older
Sex
All sexes
Disease stage
Painful diabetic peripheral neuropathy (PDPN) with documented type 2 diabetes (T2DM)
Earlier treatment
People cannot join if they take medicines that could affect blood sugar control or pain, such as systemic glucocorticoids, weight-loss agents, or iron and vitamin B12 supplements.
Main reasons for not taking part
  • Chronic kidney disease (CKD)
  • High blood pressure (hypertension)
  • Heart or blood vessel disease (CVD)
  • Problems with thinking or senses, such as reading or hearing difficulties
  • Taking systemic glucocorticoids, weight-loss agents, or iron or vitamin B12 supplements
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • Age ≥ 18years diagnosed with PDPN
  • With documented T2DM

Who cannot take part

  • If they had coexisting chronic conditions, including chronic kidney disease (CKD), hypertension, cardiovascular disease (CVD), or cognitive/sensory impairments (e.g., reading or hearing difficulties)
  • individuals receiving medications that could confound blood glucose control or pain perception (such as systemic glucocorticoids, weight-loss agents, or iron and vitamin B12 supplements)

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Painful diabetic peripheral neuropathy

This trial is currently available in Jordan.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Background: Painful diabetic peripheral neuropathy (PDPN) is a severe, disabling complication of type 2 diabetes mellitus (T2DM), closely associated with insulin resistance, chronic neuroinflammation, and oxidative stress. Plant-based dietary supplements, particularly Ceylon cinnamon (Cinnamomum verum), contain bioactive compounds with potential anti-diabetic, antioxidant, and neuroprotective properties.

Read full original descriptionShow less

Aim: To evaluate the effects of Ceylon Cinnamon (Cinnamomum verum) supplementation on blood glucose, lipid profile levels, body mass index (BMI), and pain intensity among adult individuals with painful diabetic peripheral neuropathy (PDPN).

Methods: A prospective, double-blind, randomized controlled trial (Double-Blind RCT) was conducted (Feb-July 2026) across endocrinology outpatient clinics in Jordan. Participants were randomly allocated in a 1:1 ratio to either the Intervention Group (n = 62; 500 mg Ceylon cinnamon twice daily for 6 months alongside standard care) or the Placebo Control Group (n = 62; 500 mg placebo capsules twice daily for 6 months alongside standard care). Clinical, biochemical, and pain assessments (using the Numeric Rating Scale [NRS]) were evaluated at baseline, 3 months, and 6 months post-intervention.

The 2 groups in the trial

  • Ceylon Cinnamon GroupTreatment being tested

    Participants receive Ceylon Cinnamon supplementation daily for a specified duration.

    Treatment: Ceylon Cinnamon Supplement

  • Control GroupPlacebo, for comparison

    Participants receive a matching placebo daily for the same duration.

    Treatment: Ceylon Cinnamon Supplement

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effects of Ceylon Cinnamon (Cinnamomum Verum) Supplementation on Blood Glucose, Lipid Profile Levels, Body Mass Index, and Pain Intensity Among Adult Individuals With Painful Diabetic Peripheral Neuropathy: A Double-Blind Randomized Controlled Trial
Plain-language title
Ceylon cinnamon supplement for people with painful diabetic nerve damageGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07743073, who can take part
Record updated
3 August 2026